BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19179466)

  • 1. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
    Vachon CM; Kyle RA; Therneau TM; Foreman BJ; Larson DR; Colby CL; Phelps TK; Dispenzieri A; Kumar SK; Katzmann JA; Rajkumar SV
    Blood; 2009 Jul; 114(4):785-90. PubMed ID: 19179466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
    Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
    Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.
    Landgren O; Kyle RA; Pfeiffer RM; Katzmann JA; Caporaso NE; Hayes RB; Dispenzieri A; Kumar S; Clark RJ; Baris D; Hoover R; Rajkumar SV
    Blood; 2009 May; 113(22):5412-7. PubMed ID: 19179464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
    Clay-Gilmour AI; Kumar S; Rajkumar SV; Rishi A; Kyle RA; Katzmann JA; Murray DL; Norman AD; Greenberg AJ; Larson DR; O'Byrne MM; Slager SL; Vachon CM
    Leukemia; 2019 Feb; 33(2):499-507. PubMed ID: 30201985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden.
    Landgren O; Kristinsson SY; Goldin LR; Caporaso NE; Blimark C; Mellqvist UH; Wahlin A; Bjorkholm M; Turesson I
    Blood; 2009 Jul; 114(4):791-5. PubMed ID: 19182202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory and clinical characterization of monoclonal gammopathy in Taiwanese.
    Lee LN; Jan IS; Tien HF; Lin JS; Lo SC; Cheng WC
    J Formos Med Assoc; 2002 Feb; 101(2):91-7. PubMed ID: 12099210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of monoclonal gammopathy of undetermined significance.
    Kyle RA; Therneau TM; Rajkumar SV; Larson DR; Plevak MF; Offord JR; Dispenzieri A; Katzmann JA; Melton LJ
    N Engl J Med; 2006 Mar; 354(13):1362-9. PubMed ID: 16571879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
    Greenberg AJ; Rajkumar SV; Vachon CM
    Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study.
    Landgren O; Kyle RA; Hoppin JA; Beane Freeman LE; Cerhan JR; Katzmann JA; Rajkumar SV; Alavanja MC
    Blood; 2009 Jun; 113(25):6386-91. PubMed ID: 19387005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
    Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
    Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study.
    Gupta R; Dahiya M; Kumar L; Shekhar V; Sharma A; Ramakrishnan L; Sharma OD; Begum A
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e345-e350. PubMed ID: 29980412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions.
    Atkin C; Reddy-Kolanu V; Drayson MT; Sapey E; Richter AG
    Br J Haematol; 2020 Jun; 189(6):1127-1135. PubMed ID: 31999849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal gammopathy of undetermined significance.
    Kyle RA; Rajkumar SV
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States.
    Landgren O; Gridley G; Turesson I; Caporaso NE; Goldin LR; Baris D; Fears TR; Hoover RN; Linet MS
    Blood; 2006 Feb; 107(3):904-6. PubMed ID: 16210333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence Analysis of Monoclonal Gammopathy of Undetermined Significance in People over 40 Years of Age].
    Zhang R; Wang L; Zhang ZH; Pang NN; Zhao JL; Qu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):623-628. PubMed ID: 30998181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana.
    Landgren O; Katzmann JA; Hsing AW; Pfeiffer RM; Kyle RA; Yeboah ED; Biritwum RB; Tettey Y; Adjei AA; Larson DR; Dispenzieri A; Melton LJ; Goldin LR; McMaster ML; Caporaso NE; Rajkumar SV
    Mayo Clin Proc; 2007 Dec; 82(12):1468-73. PubMed ID: 18053453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.